Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 7
Quest Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 8
Quest Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 9
Quest Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 10
Quest Diagnostics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 11
Quest Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 12
Quest Diagnostics Inc, Medical Equipment, Deal Details 15
Asset Purchase 15
Quest Diagnostics Acquires Assets from California Laboratory Associates 15
Venture Financing 16
Clinical Genomics Technologies Raises USD11.4 Million in Series A Financing Round 16
Partnerships 17
Vermillion Enters into Licensing Agreement with Quest Diagnostics 17
Clinical Genomics Enters into Licensing Agreement with CSIRO 18
Life Technologies Enters Into Licensing Agreement With Quest Diagnostics For Development Of Molecular Tests 19
Illumina Enters Into Licensing Agreement With Quest Diagnostics 20
Quest Diagnostics Enters Into Licensing Agreement With Transgenomic For Opioid Therapy Genetic Test 21
Matrix-Bio Enters Into Licensing Agreement With Quest Diagnostics For Metabolomic Biomarkers 22
Clinical Genomics Enters Into Licensing Agreement With Quest Diagnostics For Colon Cancer Markers 23
Augurex Life Sciences Enters Into Licensing Agreement With Quest Diagnostics For 14-3-3n Biomarker 24
Clinical Genomics Extends Its Licensing Agreement With Quest Diagnostics 25
Clinical Genomics Partners with Memorial Sloan Kettering Cancer Center 26
Biocept to Form Partnership with Quest Diagnostics Mexico 27
DermTech Enters into Agreement with Dermpath Diagnostics 28
Commonwealth Labs Enters into Agreement with Quest Diagnostics for IBSchek 29
Genomic Vision Extends Agreement with Quest Diagnostics 30
Thermo Fisher Scientific Enters Into Co-Marketing And Distribution Agreement With Quest Diagnostics 31
Genomic Vision Extends Co-Development Agreement With Quest Diagnostics 32
Quest Diagnostics Enters Into Co-Development Agreement With Hologic 33
PrimeraDx Enters Into Co-Development Agreement With Quest Diagnostics 34
Quest Diagnostics Enters Into Technology Integration Agreement With Appian 35
Quest Diagnostics Enters Into Agreement With Natera To Offer Panorama, Non-Invasive Prenatal Screening Test 36
Apenimed Enters Into Technology Integration Agreement With Quest Diagnostics 37
RedHill Biopharma Enters Into Co-Development Agreement With Quest Diagnostics To Develop MAP Test For Crohn’s Disease 38
Vermillion Signs Agreement With Quest Diagnostics 39
Debt Offering 40
Quest Diagnostics Raises USD500 Million in Public Offering of 3.45% Senior Notes due 2026 40
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2020 42
Quest Diagnostics Raises USD600 Million in Public Offering of Senior Notes Due 2025 44
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2045 46
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2019 For US$300 Million 48
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2024 For US$300 Million 49
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2040 For US$200 Million 50
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2014 For US$200 Million 51
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2016 For US$300 Million 52
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2021 For US$550 Million 53
Asset Transactions 54
DiaSorin Acquires Molecular and Immunoassay Product Business of Focus Diagnostics from Quest Diagnostics 54
Acquisition 56
Quest Diagnostics Acquires Shiel Medical from Fresenius Medical 56
Quest Diagnostics Acquires Cleveland HeartLab from Cleveland Clinic and Advantage Capital 57
Quest Diagnostics May Sell itself 59
Quest Diagnostics Acquires ConVerge Diagnostic Services From Water Street Healthcare 60
Clinical Genomics Acquires Enterix From Quest Diagnostics 61
Quest Diagnostics Completes Sale Of HemoCue To Radiometer Medical For US$300 Million 62
Access Genetics Acquires OralDNA Labs From Quest Diagnostics 64
Quest Diagnostics Completes Acquisition Of S.E.D. Medical Labs From Lovelace Health 65
Solstas Lab Partners Acquires NextWave Diagnostic Labs 66
Solstas Lab Partners Acquires Wilmington Pathology Lab 67
Solstas Lab Partners Acquires Select Diagnostics 68
Quest Diagnostics Completes Acquisition Of Celera 69
Quest Diagnostics Completes Acquisition Of Athena Diagnostics 71
Quest Diagnostics Inc – Key Competitors 73
Quest Diagnostics Inc – Key Employees 74
Quest Diagnostics Inc – Locations And Subsidiaries 76
Head Office 76
Other Locations & Subsidiaries 76
Joint Venture 78
Recent Developments 80
Strategy And Business Planning 80
Jan 26, 2017: Quest Diagnostics Partners With Montefiore Health System to Deliver High-Value, Innovative Laboratory Services 80
Financial Announcements 81
Oct 19, 2017: Quest Diagnostics Reports Third Quarter 2017 Financial Results 81
Jul 25, 2017: Quest Diagnostics Reports Second Quarter 2017 Financial Results, Raises 2017 Financial Outlook 82
Apr 20, 2017: Quest Diagnostics Reports First Quarter 2017 Financial Results, Raises 2017 Financial Outlook 83
Jan 26, 2017: Quest Diagnostics Reports Fourth Quarter And Full Year 2016 Financial Results; Provides Guidance For Full Year 2017 84
Nov 11, 2016: Quest Diagnostics Raises Revenue Growth Outlook, Increases Dividend at 2016 Investor Day 85
Oct 20, 2016: Quest Diagnostics Reports Third Quarter 2016 Financial Results 86
Jul 21, 2016: Quest Diagnostics Reports Second Quarter 2016 Financial Results 88
Apr 21, 2016: Quest Diagnostics Reports First Quarter 2016 Financial Results 90
Jan 28, 2016: Quest Diagnostics Reports Fourth Quarter And Full Year 2015 Financial Results; Provides Guidance For Full Year 2016; Increases Dividend 5% To $0.40 Per Quarter 91
Corporate Communications 92
Dec 15, 2016: Quest Diagnostics Board of Directors Elects Stephen H. Rusckowski Chairman of the Board 92
Legal and Regulatory 93
Dec 11, 2017: Quest Diagnostics supports suit against HHS charging that CMS ignored congressional intent in implementing new clinical lab payment system 93
Jun 15, 2017: Oxford Immunotec Announces Favorable Claim Construction Ruling in Patent Infringement Litigation 94
Oct 03, 2016: Oxford Immunotec Announces Favorable Decision from U.S. District Court of Massachusetts in Patent Infringement Litigation 95
Sep 01, 2016: Oxford Immunotec Announces Favorable Recommendation by the Magistrate Judge in Patent Infringement Litigation 96
Aug 18, 2016: Quest Diagnostics Approved to Use Electronic Drug Test Process for Federally-Mandated Workforce by U.S. Health and Human Services 97
Government and Public Interest 98
Nov 20, 2017: Quest Diagnostics Provides Update on Impact of Final 2018 Medicare Payment Rates for Clinical Laboratory Tests 98
Product News 99
Jul 19, 2017: Quest Diagnostics Launches QHerit, a Pan-Ethnic Genetic Screening Panel Aligned with New Medical Guidelines 99
Jun 01, 2016: One Year After Launch, BRCA Share Open Data Initiative Reveals New Findings on BRCA Gene Mutations Linked to Hereditary Breast and Ovarian Cancer Risk 101
May 26, 2016: Quest Diagnostics Launches Three Genetic Test Panels for Predicting Hereditary Cancer Risk 103
Apr 15, 2016: New Diagnostic Pathways Could Improve Dementia Diagnosis, According to Consensus Statements to Be Presented at the American Academy of Neurology Annual Meeting 105
Apr 14, 2016: Quest Launches New Hepatitis C Virus Test Capabilities for Recently FDA-approved Antiviral Therapies 107
Feb 24, 2016: Quest Diagnostics and Inovalon Bring Real-Time, Point-of-Care Analytics to HIMSS16 with Data Diagnostics 108
Feb 22, 2016: Quest Diagnostics to Showcase Its Advanced Healthcare Information Technology Solutions at HIMSS16 Under its New Quanum Brand 110
Other Significant Developments 112
Sep 27, 2017: Quest Diagnostics Provides Update On Impact to Third Quarter Financial Results from Hurricanes 112
Sep 26, 2017: Rx Savings Solutions Helps Quest Diagnostics’ Health Plan Members Save Money On Prescription Drugs 113
Sep 07, 2017: Quest Diagnostics Moves to Convenient Nonfasting Cholesterol Testing with Improved Method for Assessing Heart Disease Risk and Aiding Treatment Decisions 114
Aug 30, 2017: MDI Solutions selected to provide Cloverleaf Secure Courier implementation and training services 116
Jan 18, 2017: Quest Diagnostics Launches Nation’s First Hepatitis B Virus Quantitative Test to Help Assess Response to Antiviral Therapy 117
Nov 21, 2016: Quest Diagnostics to Expand Consumer Offering Through Patient-Initiated Testing Services in Colorado and Missouri 118
Sep 13, 2016: Optum and Quest Diagnostics Partner to Help Make the Health System Work Better for Patients, Physicians, Health Plans and Employers 119
Aug 03, 2016: Quest Diagnostics and AncestryDNA Collaborate to Expand Consumer DNA Testing 120
Jul 13, 2016: Apollo Enters Agreement with ChartMaxx from Quest Diagnostics to Provide Enterprise Imaging and Content Management Technology 121
Jun 15, 2016: Quest Diagnostics and Safeway Team to Offer Convenient Diagnostic Testing to Customers in More States 122
May 31, 2016: Quest Diagnostics and HCA’s HealthONE System Partner to Deliver High-Value and Innovative Laboratory Services at Six Denver-Area HealthONE Hospitals 123
Appendix 124
Methodology 124
About GlobalData 124
Contact Us 124
Disclaimer 124
Quest Diagnostics Inc, Medical Equipment, Key Facts, 2016 2
Quest Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Quest Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 8
Quest Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 9
Quest Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 10
Quest Diagnostics Inc, Deals By Market, 2011 to YTD 2017 11
Quest Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 12
Quest Diagnostics Acquires Assets from California Laboratory Associates 15
Clinical Genomics Technologies Raises USD11.4 Million in Series A Financing Round 16
Vermillion Enters into Licensing Agreement with Quest Diagnostics 17
Clinical Genomics Enters into Licensing Agreement with CSIRO 18
Life Technologies Enters Into Licensing Agreement With Quest Diagnostics For Development Of Molecular Tests 19
Illumina Enters Into Licensing Agreement With Quest Diagnostics 20
Quest Diagnostics Enters Into Licensing Agreement With Transgenomic For Opioid Therapy Genetic Test 21
Matrix-Bio Enters Into Licensing Agreement With Quest Diagnostics For Metabolomic Biomarkers 22
Clinical Genomics Enters Into Licensing Agreement With Quest Diagnostics For Colon Cancer Markers 23
Augurex Life Sciences Enters Into Licensing Agreement With Quest Diagnostics For 14-3-3n Biomarker 24
Clinical Genomics Extends Its Licensing Agreement With Quest Diagnostics 25
Clinical Genomics Partners with Memorial Sloan Kettering Cancer Center 26
Biocept to Form Partnership with Quest Diagnostics Mexico 27
DermTech Enters into Agreement with Dermpath Diagnostics 28
Commonwealth Labs Enters into Agreement with Quest Diagnostics for IBSchek 29
Genomic Vision Extends Agreement with Quest Diagnostics 30
Thermo Fisher Scientific Enters Into Co-Marketing And Distribution Agreement With Quest Diagnostics 31
Genomic Vision Extends Co-Development Agreement With Quest Diagnostics 32
Quest Diagnostics Enters Into Co-Development Agreement With Hologic 33
PrimeraDx Enters Into Co-Development Agreement With Quest Diagnostics 34
Quest Diagnostics Enters Into Technology Integration Agreement With Appian 35
Quest Diagnostics Enters Into Agreement With Natera To Offer Panorama, Non-Invasive Prenatal Screening Test 36
Apenimed Enters Into Technology Integration Agreement With Quest Diagnostics 37
RedHill Biopharma Enters Into Co-Development Agreement With Quest Diagnostics To Develop MAP Test For Crohn's Disease 38
Vermillion Signs Agreement With Quest Diagnostics 39
Quest Diagnostics Raises USD500 Million in Public Offering of 3.45% Senior Notes due 2026 40
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2020 42
Quest Diagnostics Raises USD600 Million in Public Offering of Senior Notes Due 2025 44
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2045 46
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2019 For US$300 Million 48
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2024 For US$300 Million 49
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2040 For US$200 Million 50
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2014 For US$200 Million 51
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2016 For US$300 Million 52
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2021 For US$550 Million 53
DiaSorin Acquires Molecular and Immunoassay Product Business of Focus Diagnostics from Quest Diagnostics 54
Quest Diagnostics Acquires Shiel Medical from Fresenius Medical 56
Quest Diagnostics Acquires Cleveland HeartLab from Cleveland Clinic and Advantage Capital 57
Quest Diagnostics May Sell itself 59
Quest Diagnostics Acquires ConVerge Diagnostic Services From Water Street Healthcare 60
Clinical Genomics Acquires Enterix From Quest Diagnostics 61
Quest Diagnostics Completes Sale Of HemoCue To Radiometer Medical For US$300 Million 62
Access Genetics Acquires OralDNA Labs From Quest Diagnostics 64
Quest Diagnostics Completes Acquisition Of S.E.D. Medical Labs From Lovelace Health 65
Solstas Lab Partners Acquires NextWave Diagnostic Labs 66
Solstas Lab Partners Acquires Wilmington Pathology Lab 67
Solstas Lab Partners Acquires Select Diagnostics 68
Quest Diagnostics Completes Acquisition Of Celera 69
Quest Diagnostics Completes Acquisition Of Athena Diagnostics 71
Quest Diagnostics Inc, Key Competitors 73
Quest Diagnostics Inc, Key Employees 74
Quest Diagnostics Inc, Subsidiaries 76
Quest Diagnostics Inc, Joint Venture 78